Europe Nonalcoholic Fatty Liver Disease Market Report 2016

Choose Licence

 

Notes: Sales, means the sales volume of Nonalcoholic Fatty Liver Disease Revenue, means the sales value of Nonalcoholic Fatty Liver Disease This report studies sales (consumption) of Nonalcoholic Fatty Liver Disease in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Conatus Pharmaceuticals Daewoong Pharmaceutical Galmed International Kyorin Pharmaceutical Metabolic Solutions Development Novartis AG Phenex Pharmaceuticals Raptor Pharmaceuticals TCM Biotech International Tobira Therapeutics Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Nonalcoholic Fatty Liver Disease in these countries, from 2011 to 2021 (forecast), like Germany France UK Russia Italy Spain Benelux Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by application, this report focuses on sales, market share and growth rate of Nonalcoholic Fatty Liver Disease in each application, can be divided into Application 1 Application 2 Application 3

 

Table of Contents Europe Nonalcoholic Fatty Liver Disease Market Report 2016 1 Nonalcoholic Fatty Liver Disease Overview 1.1 Product Overview and Scope of Nonalcoholic Fatty Liver Disease 1.2 Classification of Nonalcoholic Fatty Liver Disease 1.2.1 Type I 1.2.2 Type II 1.2.3 Type III 1.3 Application of Nonalcoholic Fatty Liver Disease 1.3.1 Application 1 1.3.2 Application 2 1.3.3 Application 3 1.4 Nonalcoholic Fatty Liver Disease Market by Countries 1.4.1 Germany Status and Prospect (2011-2021) 1.4.2 France Status and Prospect (2011-2021) 1.4.3 UK Status and Prospect (2011-2021) 1.4.4 Russia Status and Prospect (2011-2021) 1.4.5 Italy Status and Prospect (2011-2021) 1.4.6 Spain Status and Prospect (2011-2021) 1.4.7 Benelux Status and Prospect (2011-2021) 1.5 Europe Market Size (Value and Volume) of Nonalcoholic Fatty Liver Disease (2011-2021) 1.5.1 Europe Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2021) 1.5.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021) 2 Europe Nonalcoholic Fatty Liver Disease by Manufacturers, Type and Application 2.1 Europe Nonalcoholic Fatty Liver Disease Market Competition by Manufacturers 2.1.1 Europe Nonalcoholic Fatty Liver Disease Sales and Market Share of Key Manufacturers (2015 and 2016) 2.1.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Share by Manufacturers (2015 and 2016) 2.2 Europe Nonalcoholic Fatty Liver Disease (Volume and Value) by Type 2.2.1 Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Type (2011-2016) 2.2.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Market Share by Type (2011-2016) 2.3 Europe Nonalcoholic Fatty Liver Disease (Volume and Value) by Countries 2.3.1 Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Countries (2011-2016) 2.3.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Market Share by Countries (2011-2016) 2.4 Europe Nonalcoholic Fatty Liver Disease (Volume) by Application 3 Germany Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price) 3.1 Germany Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016) 3.1.1 Germany Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016) 3.1.2 Germany Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016) 3.1.3 Germany Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016) 3.2 Germany Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers 3.3 Germany Nonalcoholic Fatty Liver Disease Sales and Market Share by Type 3.4 Germany Nonalcoholic Fatty Liver Disease Sales and Market Share by Application 4 France Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price) 4.1 France Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016) 4.1.1 France Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016) 4.1.2 France Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016) 4.1.4 France Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016) 4.2 France Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers 4.3 France Nonalcoholic Fatty Liver Disease Sales and Market Share by Type 4.4 France Nonalcoholic Fatty Liver Disease Sales and Market Share by Application 5 UK Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price) 5.1 UK Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016) 5.1.1 UK Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016) 5.1.2 UK Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016) 5.1.5 UK Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016) 5.2 UK Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers 5.3 UK Nonalcoholic Fatty Liver Disease Sales and Market Share by Type 5.4 UK Nonalcoholic Fatty Liver Disease Sales and Market Share by Application 6 Russia Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price) 6.1 Russia Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016) 6.1.1 Russia Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016) 6.1.2 Russia Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016) 6.1.6 Russia Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016) 6.2 Russia Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers 6.3 Russia Nonalcoholic Fatty Liver Disease Sales and Market Share by Type 6.4 Russia Nonalcoholic Fatty Liver Disease Sales and Market Share by Application 7 Italy Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price) 7.1 Italy Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016) 7.1.1 Italy Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016) 7.1.2 Italy Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016) 7.1.7 Italy Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016) 7.2 Italy Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers 7.3 Italy Nonalcoholic Fatty Liver Disease Sales and Market Share by Type 7.4 Italy Nonalcoholic Fatty Liver Disease Sales and Market Share by Application 8 Spain Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price) 8.1 Spain Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016) 8.1.1 Spain Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016) 8.1.2 Spain Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016) 8.1.8 Spain Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016) 8.2 Spain Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers 8.3 Spain Nonalcoholic Fatty Liver Disease Sales and Market Share by Type 8.4 Spain Nonalcoholic Fatty Liver Disease Sales and Market Share by Application 9 Benelux Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price) 9.1 Benelux Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016) 9.1.1 Benelux Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016) 9.1.2 Benelux Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016) 9.1.9 Benelux Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016) 9.2 Benelux Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers 9.3 Benelux Nonalcoholic Fatty Liver Disease Sales and Market Share by Type 9.4 Benelux Nonalcoholic Fatty Liver Disease Sales and Market Share by Application 10 Europe Nonalcoholic Fatty Liver Disease Manufacturers Analysis 10.1 Conatus Pharmaceuticals 10.1.1 Company Basic Information, Manufacturing Base and Competitors 10.1.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification 10.1.2.1 Type I 10.1.2.2 Type II 10.1.3 Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016) 10.1.4 Main Business/Business Overview 10.2 Daewoong Pharmaceutical 10.2.1 Company Basic Information, Manufacturing Base and Competitors 10.2.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification 10.2.2.1 Type I 10.2.2.2 Type II 10.2.3 Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016) 10.2.4 Main Business/Business Overview 10.3 Galmed International 10.3.1 Company Basic Information, Manufacturing Base and Competitors 10.3.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification 10.3.2.1 Type I 10.3.2.2 Type II 10.3.3 Galmed International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016) 10.3.4 Main Business/Business Overview 10.4 Kyorin Pharmaceutical 10.4.1 Company Basic Information, Manufacturing Base and Competitors 10.4.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification 10.4.2.1 Type I 10.4.2.2 Type II 10.4.3 Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016) 10.4.4 Main Business/Business Overview 10.5 Metabolic Solutions Development 10.5.1 Company Basic Information, Manufacturing Base and Competitors 10.5.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification 10.5.2.1 Type I 10.5.2.2 Type II 10.5.3 Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016) 10.5.4 Main Business/Business Overview 10.6 Novartis AG 10.6.1 Company Basic Information, Manufacturing Base and Competitors 10.6.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification 10.6.2.1 Type I 10.6.2.2 Type II 10.6.3 Novartis AG Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016) 10.6.4 Main Business/Business Overview 10.7 Phenex Pharmaceuticals 10.7.1 Company Basic Information, Manufacturing Base and Competitors 10.7.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification 10.7.2.1 Type I 10.7.2.2 Type II 10.7.3 Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016) 10.7.4 Main Business/Business Overview 10.8 Raptor Pharmaceuticals 10.8.1 Company Basic Information, Manufacturing Base and Competitors 10.8.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification 10.8.2.1 Type I 10.8.2.2 Type II 10.8.3 Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016) 10.8.4 Main Business/Business Overview 10.9 TCM Biotech International 10.9.1 Company Basic Information, Manufacturing Base and Competitors 10.9.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification 10.9.2.1 Type I 10.9.2.2 Type II 10.9.3 TCM Biotech International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016) 10.9.4 Main Business/Business Overview 10.10 Tobira Therapeutics 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification 10.10.2.1 Type I 10.10.2.2 Type II 10.10.3 Tobira Therapeutics Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016) 10.10.4 Main Business/Business Overview 11 Nonalcoholic Fatty Liver Disease Manufacturing Cost Analysis 11.1 Nonalcoholic Fatty Liver Disease Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.1.2 Price Trend of Key Raw Materials 11.1.3 Key Suppliers of Raw Materials 11.1.4 Market Concentration Rate of Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease 12 Industrial Chain, Sourcing Strategy and Downstream Buyers 12.1 Nonalcoholic Fatty Liver Disease Industrial Chain Analysis 12.2 Upstream Raw Materials Sourcing 12.3 Raw Materials Sources of Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015 12.4 Downstream Buyers 13 Marketing Strategy Analysis, Distributors/Traders 13.1 Marketing Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Development Trend 13.2 Market Positioning 13.2.1 Pricing Strategy 13.2.2 Brand Strategy 13.2.3 Target Client 13.3 Distributors/Traders List 14 Europe Nonalcoholic Fatty Liver Disease Market Forecast (2016-2021) 14.1 Germany Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021) 14.2 France Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021) 14.3 UK Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021) 14.4 Russia Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021) 14.5 Italy Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021) 14.6 Spain Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021) 14.7 Benelux Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021) 14.8 Europe Nonalcoholic Fatty Liver Disease Sales Forecast by Type (2016-2021) 14.9 Europe Nonalcoholic Fatty Liver Disease Sales Forecast by Application (2016-2021) 15 Research Findings and Conclusion 16 Appendix Author List Disclosure Section Research Methodology Data Source Disclaimer

List of Tables and Figures Figure Picture of Nonalcoholic Fatty Liver Disease Table Classification of Nonalcoholic Fatty Liver Disease Figure Europe Sales Market Share of Nonalcoholic Fatty Liver Disease by Type in 2015 Figure Type I Picture Figure Type II Picture Table Application of Nonalcoholic Fatty Liver Disease Figure Europe Sales Market Share of Nonalcoholic Fatty Liver Disease by Application in 2015 Figure Application 1 Examples Figure Application 2 Examples Figure Germany Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021) Figure France Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021) Figure UK Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021) Figure Russia Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021) Figure Italy Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021) Figure Spain Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021) Figure Benelux Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021) Figure Europe Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2021) Figure Europe Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021) Table Europe Nonalcoholic Fatty Liver Disease Sales of Key Manufacturers (2015 and 2016) Table Europe Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers (2015 and 2016) Figure 2015 Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers Figure 2016 Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers Table Europe Nonalcoholic Fatty Liver Disease Revenue by Manufacturers (2015 and 2016) Table Europe Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers (2015 and 2016) Table 2015 Europe Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers Table 2016 Europe Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers Table Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Type (2011-2016) Table Europe Nonalcoholic Fatty Liver Disease Sales Share by Type (2011-2016) Figure Sales Market Share of Nonalcoholic Fatty Liver Disease by Type (2011-2016) Figure Europe Nonalcoholic Fatty Liver Disease Sales Growth Rate by Type (2011-2016) Table Europe Nonalcoholic Fatty Liver Disease Revenue and Market Share by Type (2011-2016) Table Europe Nonalcoholic Fatty Liver Disease Revenue Share by Type (2011-2016) Figure Revenue Market Share of Nonalcoholic Fatty Liver Disease by Type (2011-2016) Figure Europe Nonalcoholic Fatty Liver Disease Revenue Growth Rate by Type (2011-2016) Table Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Countries (2011-2016) Table Europe Nonalcoholic Fatty Liver Disease Sales Share by Countries (2011-2016) Figure Sales Market Share of Nonalcoholic Fatty Liver Disease by Countries (2011-2016) Table Europe Nonalcoholic Fatty Liver Disease Revenue and Market Share by Countries (2011-2016) Table Europe Nonalcoholic Fatty Liver Disease Revenue Share by Countries (2011-2016) Figure Revenue Market Share of Nonalcoholic Fatty Liver Disease by Countries (2011-2016) Table Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Application (2011-2016) Table Europe Nonalcoholic Fatty Liver Disease Sales Share by Application (2011-2016) Figure Sales Market Share of Nonalcoholic Fatty Liver Disease by Application (2011-2016) Figure Germany Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016) Figure Germany Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016) Figure Germany Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016) Table Germany Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016) Table Germany Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016) Table Germany Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016) Table Germany Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016) Table Germany Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016) Table Germany Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016) Figure France Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016) Figure France Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016) Figure France Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016) Table France Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016) Table France Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016) Table France Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016) Table France Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016) Table France Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016) Table France Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016) Figure UK Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016) Figure UK Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016) Figure UK Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016) Table UK Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016) Table UK Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016) Table UK Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016) Table UK Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016) Table UK Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016) Table UK Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016) Figure Russia Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016) Figure Russia Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016) Figure Russia Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016) Table Russia Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016) Table Russia Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016) Table Russia Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016) Table Russia Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016) Table Russia Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016) Table Russia Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016) Figure Italy Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016) Figure Italy Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016) Figure Italy Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016) Table Italy Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016) Table Italy Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016) Table Italy Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016) Table Italy Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016) Table Italy Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016) Table Italy Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016) Figure Spain Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016) Figure Spain Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016) Figure Spain Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016) Table Spain Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016) Table Spain Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016) Table Spain Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016) Table Spain Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016) Table Spain Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016) Table Spain Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016) Figure Benelux Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016) Figure Benelux Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016) Figure Benelux Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016) Table Benelux Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016) Table Benelux Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016) Table Benelux Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016) Table Benelux Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016) Table Benelux Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016) Table Benelux Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016) Table Nonalcoholic Fatty Liver Disease Basic Information List Table Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016) Figure Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016) Table Daewoong Pharmaceutical Basic Information List Table Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016) Table Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016) Table Galmed International Basic Information List Table Galmed International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016) Table Galmed International Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016) Table Kyorin Pharmaceutical Basic Information List Table Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016) Table Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016) Table Metabolic Solutions Development Basic Information List Table Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016) Table Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016) Table Novartis AG Basic Information List Table Novartis AG Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016) Table Novartis AG Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016) Table Phenex Pharmaceuticals Basic Information List Table Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016) Table Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016) Table Raptor Pharmaceuticals Basic Information List Table Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016) Table Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016) Table TCM Biotech International Basic Information List Table TCM Biotech International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016) Table TCM Biotech International Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016) Table Tobira Therapeutics Basic Information List Table Tobira Therapeutics Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016) Table Tobira Therapeutics Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016) Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Nonalcoholic Fatty Liver Disease Figure Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease Figure Nonalcoholic Fatty Liver Disease Industrial Chain Analysis Table Raw Materials Sources of Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015 Table Major Buyers of Nonalcoholic Fatty Liver Disease Table Distributors/Traders List Figure Germany Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021) Figure Germany Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021) Figure France Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021) Figure France Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021) Figure UK Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021) Figure UK Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021) Figure Russia Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021) Figure Russia Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021) Figure Italy Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021) Figure Italy Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021) Figure Spain Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021) Figure Spain Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021) Figure Benelux Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021) Figure Benelux Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021) Table Europe Nonalcoholic Fatty Liver Disease Sales Forecast by Type (2016-2021) Table Europe Nonalcoholic Fatty Liver Disease Sales Forecast by Application (2016-2021)

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Other Reports by QY Research

Global Plastic Injection Molding Market Professional Survey Report 2017

This report studies Plastic Injection Molding in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to...

Global Industrial Film Market Professional Survey Report 2017

This report studies Industrial Film in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. ...

Global Styrofoam Coolers Market Professional Survey Report 2017

This report studies Styrofoam Coolers in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. ...

Global Spray Dryer Market Professional Survey Report 2017

This report studies Spray Dryer in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This...

Global Smart Wearable Lifestyle Devices Market Professional Survey Report 2017

This report studies Smart Wearable Lifestyle Devices in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and fore...

New Pharmaceuticals and Healthcare Reports